FDA Okays First Generic Naloxone Nasal Spray for Opioid Overdose FDA Okays First Generic Naloxone Nasal Spray for Opioid Overdose

The FDA has granted final approval for the first generic naloxone hydrochloride nasal spray for reversing or stopping the effects from an opioid overdose.FDA Approvals

Source: Medscape Psychiatry Headlines - April 19, 2019 Category: Psychiatry Tags: Psychiatry News Alert Source Type: news